Upgrades
For Herbalife Nutrition Ltd (NYSE:HLF), Jefferies upgraded the previous rating of Hold to Buy. For the first quarter, Herbalife Nutrition had an EPS of $0.99, compared to year-ago quarter EPS of $1.42. The stock has a 52-week-high of $54.45 and a 52-week-low of $19.30. At the end of the last trading period, Herbalife Nutrition closed at $19.71.
According to Susquehanna, the prior rating for Southwest Airlines Co (NYSE:LUV) was changed from Neutral to Positive. For the first quarter, Southwest Airlines had an EPS of $0.32, compared to year-ago quarter EPS of $1.72. At the moment, the stock has a 52-week-high of $56.33 and a 52-week-low of $34.36. Southwest Airlines closed at $36.83 at the end of the last trading period.
For Ryan Specialty Holdings Inc (NYSE:RYAN), Goldman Sachs upgraded the previous rating of Neutral to Buy. The current stock performance of Ryan Specialty Holdings shows a 52-week-high of $42.43 and a 52-week-low of $25.57. Moreover, at the end of the last trading period, the closing price was at $39.70.
For Fate Therapeutics Inc (NASDAQ:FATE), BMO Capital upgraded the previous rating of Market Perform to Outperform. Fate Therapeutics earned $0.68 in the first quarter, compared to $0.48 in the year-ago quarter. The stock has a 52-week-high of $97.43 and a 52-week-low of $17.10. At the end of the last trading period, Fate Therapeutics closed at $28.51.
According to Northcoast Research, the prior rating for Sherwin-Williams Co (NYSE:SHW) was changed from Neutral to Buy. In the first quarter, Sherwin-Williams showed an EPS of $1.61, compared to $2.06 from the year-ago quarter. The current stock performance of Sherwin-Williams shows a 52-week-high of $354.15 and a 52-week-low of $214.22. Moreover, at the end of the last trading period, the closing price was at $241.96.
For JPMorgan Chase & Co (NYSE:JPM), Citigroup upgraded the previous rating of Neutral to Buy. JPMorgan Chase earned $2.63 in the first quarter, compared to $4.50 in the year-ago quarter. The stock has a 52-week-high of $172.96 and a 52-week-low of $109.30. At the end of the last trading period, JPMorgan Chase closed at $112.86.
According to Stifel, the prior rating for Glaukos Corp (NYSE:GKOS) was changed from Hold to Buy. Glaukos earned $0.38 in the first quarter, compared to $0.21 in the year-ago quarter. The current stock performance of Glaukos shows a 52-week-high of $78.20 and a 52-week-low of $33.33. Moreover, at the end of the last trading period, the closing price was at $47.06.
For DCP Midstream LP (NYSE:DCP), RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the first quarter, DCP Midstream had an EPS of $0.32, compared to year-ago quarter EPS of $0.19. The current stock performance of DCP Midstream shows a 52-week-high of $39.54 and a 52-week-low of $23.57. Moreover, at the end of the last trading period, the closing price was at $29.19.
See all analyst ratings upgrades.
Downgrades
For JetBlue Airways Corp (NASDAQ:JBLU), Susquehanna downgraded the previous rating of Positive to Neutral. For the first quarter, JetBlue Airways had an EPS of $0.80, compared to year-ago quarter EPS of $1.48. At the moment, the stock has a 52-week-high of $16.65 and a 52-week-low of $7.96. JetBlue Airways closed at $8.04 at the end of the last trading period.
For Cardlytics Inc (NASDAQ:CDLX), Craig-Hallum downgraded the previous rating of Buy to Hold. For the first quarter, Cardlytics had an EPS of $0.38, compared to year-ago quarter EPS of $0.34. The stock has a 52-week-high of $134.91 and a 52-week-low of $16.39. At the end of the last trading period, Cardlytics closed at $16.55.
According to Morgan Stanley, the prior rating for SEI Investments Co (NASDAQ:SEIC) was changed from Equal-Weight to Underweight. For the first quarter, SEI Investments had an EPS of $1.36, compared to year-ago quarter EPS of $0.89. At the moment, the stock has a 52-week-high of $65.22 and a 52-week-low of $51.34. SEI Investments closed at $53.93 at the end of the last trading period.
According to BMO Capital, the prior rating for Macrogenics Inc (NASDAQ:MGNX) was changed from Outperform to Market Perform. For the first quarter, Macrogenics had an EPS of $1.08, compared to year-ago quarter EPS of $0.90. At the moment, the stock has a 52-week-high of $28.19 and a 52-week-low of $2.13. Macrogenics closed at $3.55 at the end of the last trading period.
Morgan Stanley downgraded the previous rating for National Retail Properties Inc (NYSE:NNN) from Overweight to Equal-Weight. National Retail Props earned $0.77 in the first quarter, compared to $0.69 in the year-ago quarter. The current stock performance of National Retail Props shows a 52-week-high of $49.99 and a 52-week-low of $39.12. Moreover, at the end of the last trading period, the closing price was at $44.83.
For STORE Capital Corp (NYSE:STOR), Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. For the first quarter, STORE Capital had an EPS of $0.57, compared to year-ago quarter EPS of $0.47. The current stock performance of STORE Capital shows a 52-week-high of $37.13 and a 52-week-low of $24.48. Moreover, at the end of the last trading period, the closing price was at $26.90.
For American Express Co (NYSE:AXP), Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the first quarter, American Express had an EPS of $2.73, compared to year-ago quarter EPS of $2.74. At the moment, the stock has a 52-week-high of $199.55 and a 52-week-low of $134.30. American Express closed at $140.58 at the end of the last trading period.
According to Morgan Stanley, the prior rating for Capital One Financial Corp (NYSE:COF) was changed from Overweight to Equal-Weight. For the first quarter, Capital One Financial had an EPS of $5.62, compared to year-ago quarter EPS of $7.03. At the moment, the stock has a 52-week-high of $177.95 and a 52-week-low of $98.54. Capital One Financial closed at $107.17 at the end of the last trading period.
According to Deutsche Bank, the prior rating for 1Life Healthcare Inc (NASDAQ:ONEM) was changed from Buy to Hold. 1Life Healthcare earned $0.47 in the first quarter, compared to $0.29 in the year-ago quarter. At the moment, the stock has a 52-week-high of $31.63 and a 52-week-low of $5.94. 1Life Healthcare closed at $10.45 at the end of the last trading period.
Wells Fargo downgraded the previous rating for Gap Inc (NYSE:GPS) from Overweight to Equal-Weight. For the first quarter, Gap had an EPS of $0.44, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $32.52 and a 52-week-low of $8.16. At the end of the last trading period, Gap closed at $8.76.
According to Wolfe Research, the prior rating for Old Dominion Freight Line Inc (NASDAQ:ODFL) was changed from Peer Perform to Underperform. Old Dominion Freight Line earned $2.60 in the first quarter, compared to $1.70 in the year-ago quarter. The current stock performance of Old Dominion Freight Line shows a 52-week-high of $373.58 and a 52-week-low of $231.31. Moreover, at the end of the last trading period, the closing price was at $269.53.
According to Wolfe Research, the prior rating for Expeditors International of Washington Inc (NASDAQ:EXPD) was changed from Peer Perform to Underperform. In the first quarter, Expeditors International showed an EPS of $2.05, compared to $1.67 from the year-ago quarter. At the moment, the stock has a 52-week-high of $137.80 and a 52-week-low of $93.77. Expeditors International closed at $97.33 at the end of the last trading period.
For C.H. Robinson Worldwide Inc (NASDAQ:CHRW), Wolfe Research downgraded the previous rating of Outperform to Peer Perform. For the first quarter, C.H. Robinson Worldwide had an EPS of $2.05, compared to year-ago quarter EPS of $1.28. The current stock performance of C.H. Robinson Worldwide shows a 52-week-high of $115.99 and a 52-week-low of $84.67. Moreover, at the end of the last trading period, the closing price was at $97.90.
According to JP Morgan, the prior rating for Lennar Corp (NYSE:LEN) was changed from Overweight to Neutral. Lennar earned $4.69 in the second quarter, compared to $2.95 in the year-ago quarter. The stock has a 52-week-high of $117.54 and a 52-week-low of $62.54. At the end of the last trading period, Lennar closed at $78.70.
For RenaissanceRe Holdings Ltd (NYSE:RNR), Jefferies downgraded the previous rating of Buy to Hold. For the first quarter, RenaissanceRe Holdings had an EPS of $3.50, compared to year-ago quarter EPS of $0.09. At the moment, the stock has a 52-week-high of $174.54 and a 52-week-low of $134.70. RenaissanceRe Holdings closed at $150.66 at the end of the last trading period.
Oppenheimer downgraded the previous rating for Capital One Financial Corp (NYSE:COF) from Outperform to Perform. Capital One Financial earned $5.62 in the first quarter, compared to $7.03 in the year-ago quarter. At the moment, the stock has a 52-week-high of $177.95 and a 52-week-low of $98.54. Capital One Financial closed at $107.17 at the end of the last trading period.
Citigroup downgraded the previous rating for Regions Financial Corp (NYSE:RF) from Buy to Neutral. In the first quarter, Regions Financial showed an EPS of $0.55, compared to $0.63 from the year-ago quarter. The current stock performance of Regions Financial shows a 52-week-high of $25.57 and a 52-week-low of $18.02. Moreover, at the end of the last trading period, the closing price was at $19.05.
JP Morgan downgraded the previous rating for Norfolk Southern Corp (NYSE:NSC) from Overweight to Neutral. In the first quarter, Norfolk Southern showed an EPS of $2.93, compared to $2.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $299.19 and a 52-week-low of $219.31. Norfolk Southern closed at $225.57 at the end of the last trading period.
JP Morgan downgraded the previous rating for Union Pacific Corp (NYSE:UNP) from Overweight to Neutral. Union Pacific earned $2.57 in the first quarter, compared to $2.00 in the year-ago quarter. The stock has a 52-week-high of $278.94 and a 52-week-low of $195.68. At the end of the last trading period, Union Pacific closed at $209.87.
See all analyst ratings downgrades.
Initiations
With an Outperform rating, Noble Capital Markets initiated coverage on Direct Digital Holdings Inc (NASDAQ:DRCT). The price target seems to have been set at $5.50 for Direct Digital Holdings. In the first quarter, Direct Digital Holdings showed an EPS of $0.09, compared to $23.68 from the year-ago quarter. At the moment, the stock has a 52-week-high of $5.49 and a 52-week-low of $1.16. Direct Digital Holdings closed at $1.33 at the end of the last trading period.
Northland Capital Markets initiated coverage on Evolution Petroleum Corp (AMEX:EPM) with an Outperform rating. The price target for Evolution Petroleum is set to $8.60. For the third quarter, Evolution Petroleum had an EPS of $0.17, compared to year-ago quarter EPS of $0.04. At the moment, the stock has a 52-week-high of $8.17 and a 52-week-low of $3.60. Evolution Petroleum closed at $5.10 at the end of the last trading period.
Aegis Capital initiated coverage on Stereotaxis Inc (AMEX:STXS) with a Buy rating. The price target for Stereotaxis is set to $6.00. Stereotaxis earned $0.06 in the first quarter, compared to $0.02 in the year-ago quarter. The current stock performance of Stereotaxis shows a 52-week-high of $10.09 and a 52-week-low of $1.72. Moreover, at the end of the last trading period, the closing price was at $2.06.
Truist Securities initiated coverage on Scholar Rock Holding Corp (NASDAQ:SRRK) with a Buy rating. The price target for Scholar Rock Holding is set to $20.00. In the first quarter, Scholar Rock Holding showed an EPS of $0.21, compared to $0.76 from the year-ago quarter. The current stock performance of Scholar Rock Holding shows a 52-week-high of $44.95 and a 52-week-low of $4.33. Moreover, at the end of the last trading period, the closing price was at $8.09.
Janney Montgomery Scott initiated coverage on Great Elm Capital Corp (NASDAQ:GECC) with a Neutral rating. In the first quarter, Great Elm Capital showed an EPS of $1.31, compared to $0.06 from the year-ago quarter. The current stock performance of Great Elm Capital shows a 52-week-high of $16.98 and a 52-week-low of $2.85. Moreover, at the end of the last trading period, the closing price was at $12.50.
With a Neutral rating, Goldman Sachs initiated coverage on Aon PLC (NYSE:AON). The price target seems to have been set at $301.00 for Aon. Aon earned $4.83 in the first quarter, compared to $4.28 in the year-ago quarter. The current stock performance of Aon shows a 52-week-high of $341.98 and a 52-week-low of $223.19. Moreover, at the end of the last trading period, the closing price was at $274.04.
With a Buy rating, Goldman Sachs initiated coverage on Marsh & McLennan Companies Inc (NYSE:MMC). The price target seems to have been set at $182.00 for Marsh & McLennan. Marsh & McLennan earned $2.30 in the first quarter, compared to $1.99 in the year-ago quarter. At the moment, the stock has a 52-week-high of $183.14 and a 52-week-low of $137.85. Marsh & McLennan closed at $155.38 at the end of the last trading period.
For Gladstone Capital Corp (NASDAQ:GLAD), Janney Montgomery Scott initiated coverage, by setting the current rating at Neutral. For the second quarter, Gladstone Capital had an EPS of $0.25, compared to year-ago quarter EPS of $0.20. At the moment, the stock has a 52-week-high of $12.78 and a 52-week-low of $9.43. Gladstone Capital closed at $10.63 at the end of the last trading period.
Goldman Sachs initiated coverage on Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) with a Neutral rating. The price target for Allscripts Healthcare is set to $21.00. Allscripts Healthcare earned $0.13 in the first quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $23.25 and a 52-week-low of $13.05. Allscripts Healthcare closed at $14.35 at the end of the last trading period.
Goldman Sachs initiated coverage on HealthEquity Inc (NASDAQ:HQY) with a Sell rating. The price target for HealthEquity is set to $59.00. HealthEquity earned $0.27 in the first quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $80.50 and a 52-week-low of $36.80. At the end of the last trading period, HealthEquity closed at $61.85.
With a Neutral rating, Goldman Sachs initiated coverage on Willis Towers Watson PLC (NASDAQ:WTW). The price target seems to have been set at $227.00 for Willis Towers Watson. For the first quarter, Willis Towers Watson had an EPS of $2.66, compared to year-ago quarter EPS of $3.64. The current stock performance of Willis Towers Watson shows a 52-week-high of $244.73 and a 52-week-low of $187.89. Moreover, at the end of the last trading period, the closing price was at $199.24.
Goldman Sachs initiated coverage on Brown & Brown Inc (NYSE:BRO) with a Neutral rating. The price target for Brown & Brown is set to $67.00. In the first quarter, Brown & Brown showed an EPS of $0.78, compared to $0.70 from the year-ago quarter. The stock has a 52-week-high of $74.00 and a 52-week-low of $52.22. At the end of the last trading period, Brown & Brown closed at $59.65.
With a Buy rating, Goldman Sachs initiated coverage on Arthur J. Gallagher & Co (NYSE:AJG). The price target seems to have been set at $198.00 for Arthur J. Gallagher. For the first quarter, Arthur J. Gallagher had an EPS of $2.81, compared to year-ago quarter EPS of $2.02. The stock has a 52-week-high of $187.02 and a 52-week-low of $135.50. At the end of the last trading period, Arthur J. Gallagher closed at $165.84.
With a Buy rating, UBS initiated coverage on Braze Inc (NASDAQ:BRZE). The price target seems to have been set at $53.00 for Braze. In the first quarter, Braze showed an EPS of $0.19, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $98.78 and a 52-week-low of $27.09. At the end of the last trading period, Braze closed at $42.17.
With an Outperform rating, Cowen & Co. initiated coverage on Alpha Metallurgical Resources Inc (NYSE:AMR). The price target seems to have been set at $215.00 for Alpha Metallurgical. Alpha Metallurgical earned $20.52 in the first quarter, compared to $1.78 in the year-ago quarter. The current stock performance of Alpha Metallurgical shows a 52-week-high of $186.98 and a 52-week-low of $21.28. Moreover, at the end of the last trading period, the closing price was at $115.18.
Cowen & Co. initiated coverage on Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) with an Outperform rating. For the first quarter, Zentalis Pharmaceuticals had an EPS of $1.31, compared to year-ago quarter EPS of $1.24. The stock has a 52-week-high of $87.19 and a 52-week-low of $17.33. At the end of the last trading period, Zentalis Pharmaceuticals closed at $27.16.
With a Buy rating, EF Hutton initiated coverage on AgriFORCE Growing Systems Ltd (NASDAQ:AGRI). The price target seems to have been set at $5.00 for AgriFORCE Growing Systems. For the first quarter, AgriFORCE Growing Systems had an EPS of $0.22, compared to year-ago quarter EPS of $0.10. The current stock performance of AgriFORCE Growing Systems shows a 52-week-high of $8.45 and a 52-week-low of $1.12. Moreover, at the end of the last trading period, the closing price was at $2.13.
Cantor Fitzgerald initiated coverage on Kura Oncology Inc (NASDAQ:KURA) with an Overweight rating. The price target for Kura Oncology is set to $30.00. For the first quarter, Kura Oncology had an EPS of $0.49, compared to year-ago quarter EPS of $0.46. At the moment, the stock has a 52-week-high of $21.19 and a 52-week-low of $10.41. Kura Oncology closed at $17.24 at the end of the last trading period.
Goldman Sachs initiated coverage on MultiPlan Corp (NYSE:MPLN) with a Neutral rating. The price target for MultiPlan is set to $6.50. MultiPlan earned $0.07 in the first quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $8.26 and a 52-week-low of $3.25. MultiPlan closed at $5.49 at the end of the last trading period.
BMO Capital initiated coverage on Harsco Corp (NYSE:HSC) with a Market Perform rating. The price target for Harsco is set to $7.00. For the first quarter, Harsco had an EPS of $0.01, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $20.75 and a 52-week-low of $6.21. At the end of the last trading period, Harsco closed at $6.38.
Piper Sandler initiated coverage on Elanco Animal Health Inc (NYSE:ELAN) with a Neutral rating. The price target for Elanco Animal Health is set to $22.00. Elanco Animal Health earned $0.36 in the first quarter, compared to $0.37 in the year-ago quarter. The current stock performance of Elanco Animal Health shows a 52-week-high of $37.49 and a 52-week-low of $19.34. Moreover, at the end of the last trading period, the closing price was at $20.22.
With an Overweight rating, Piper Sandler initiated coverage on Zoetis Inc (NYSE:ZTS). The price target seems to have been set at $205.00 for Zoetis. In the first quarter, Zoetis showed an EPS of $1.32, compared to $1.26 from the year-ago quarter. The stock has a 52-week-high of $249.27 and a 52-week-low of $154.18. At the end of the last trading period, Zoetis closed at $177.04.
Piper Sandler initiated coverage on IDEXX Laboratories Inc (NASDAQ:IDXX) with an Overweight rating. The price target for IDEXX Laboratories is set to $440.00. In the first quarter, IDEXX Laboratories showed an EPS of $2.27, compared to $2.35 from the year-ago quarter. The current stock performance of IDEXX Laboratories shows a 52-week-high of $706.95 and a 52-week-low of $318.50. Moreover, at the end of the last trading period, the closing price was at $369.66.
With a Neutral rating, Piper Sandler initiated coverage on Neogen Corp (NASDAQ:NEOG). The price target seems to have been set at $25.00 for Neogen. In the third quarter, Neogen showed an EPS of $0.13, compared to $0.25 from the year-ago quarter. The stock has a 52-week-high of $47.80 and a 52-week-low of $22.12. At the end of the last trading period, Neogen closed at $22.88.
With a Strong Buy rating, Raymond James initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA). The price target seems to have been set at $29.00 for Avidity Biosciences. Avidity Biosciences earned $0.71 in the first quarter, compared to $0.64 in the year-ago quarter. The stock has a 52-week-high of $29.25 and a 52-week-low of $10.89. At the end of the last trading period, Avidity Biosciences closed at $16.33.
With an Outperform rating, Raymond James initiated coverage on Dyne Therapeutics Inc (NASDAQ:DYN). The price target seems to have been set at $15.00 for Dyne Therapeutics. Dyne Therapeutics earned $0.69 in the first quarter, compared to $0.50 in the year-ago quarter. The current stock performance of Dyne Therapeutics shows a 52-week-high of $21.45 and a 52-week-low of $4.30. Moreover, at the end of the last trading period, the closing price was at $8.58.
Rosenblatt initiated coverage on Avid Technology Inc (NASDAQ:AVID) with a Neutral rating. The price target for Avid Technology is set to $30.00. Avid Technology earned $0.33 in the first quarter, compared to $0.28 in the year-ago quarter. At the moment, the stock has a 52-week-high of $40.48 and a 52-week-low of $20.83. Avid Technology closed at $28.88 at the end of the last trading period.
Rosenblatt initiated coverage on Universal Electronics Inc (NASDAQ:UEIC) with a Buy rating. The price target for Universal Electronics is set to $40.00. Universal Electronics earned $0.47 in the first quarter, compared to $0.89 in the year-ago quarter. The stock has a 52-week-high of $53.07 and a 52-week-low of $24.07. At the end of the last trading period, Universal Electronics closed at $24.16.
With a Buy rating, Rosenblatt initiated coverage on Universal Technical Institute Inc (NYSE:UTI). The price target seems to have been set at $11.00 for Universal Technical. For the second quarter, Universal Technical had an EPS of $0.19, compared to year-ago quarter EPS of $0.02. The current stock performance of Universal Technical shows a 52-week-high of $11.45 and a 52-week-low of $5.34. Moreover, at the end of the last trading period, the closing price was at $7.34.
With an Overweight rating, Piper Sandler initiated coverage on California Bancorp (NASDAQ:CALB). The price target seems to have been set at $22.00 for California Bancorp. In the first quarter, California Bancorp showed an EPS of $0.44, compared to $0.34 from the year-ago quarter. The stock has a 52-week-high of $24.00 and a 52-week-low of $16.98. At the end of the last trading period, California Bancorp closed at $19.26.
JP Morgan initiated coverage on Vera Therapeutics Inc (NASDAQ:VERA) with an Overweight rating. The price target for Vera Therapeutics is set to $35.00. Vera Therapeutics earned $0.71 in the first quarter, compared to $12.23 in the year-ago quarter. The current stock performance of Vera Therapeutics shows a 52-week-high of $37.11 and a 52-week-low of $12.29. Moreover, at the end of the last trading period, the closing price was at $13.51.
